Related Experiment Video
Updated: May 14, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Awareness, attitudes, and perceived barriers to artificial intelligence adoption in Turkish clinical biochemistry
Said İncir1,2, Kerim Erhan Palaoğlu3, Osman Oğuz3
1Department of Medical Biochemistry, Koç University School of Medicine, İstanbul, Türkiye.
Abstract:
BackgroundArtificial intelligence (AI) is increasingly recognized as transformative in laboratory medicine, yet adoption lags behind radiology and cardiology. Limited data exist on AI-related attitudes and perceived barriers in Turkish clinical laboratories. This study evaluated professional awareness, attitudes, and perceived barriers to AI adoption among Turkish clinical laboratory professionals.MethodsA cross-sectional survey was conducted among Turkish clinical biochemistry staff between May and June 2025. The 30-item questionnaire covered demographics, AI knowledge, training, current use, future perspectives, and ethical or legal concerns. In total, 170 eligible participants, including laboratory directors, physicians, residents, and technologists, completed the survey.ResultsAmong the participants, 43% self-rated their AI knowledge as "basic," with no participant aged ≥60 years reporting good or expert-level knowledge. The greatest knowledge deficits were in image processing (49.4% reported "no knowledge") and predictive analytics (35.9%). More than half (57.6%) had never received AI-related training, and current use of AI tools in routine practice was minimal. Despite these gaps, attitudes toward AI implementation were overwhelmingly positive, with 75.3% believing increased AI use would improve job satisfaction and 59.4% expecting laboratory transition to AI-supported systems within 5 years. Major barriers included insufficient digital infrastructure (47%), absence of trained personnel (83.5%), lack of standard operating procedures (70%), and inadequate legal/ethical regulations (52.9%).ConclusionsAI implementation in Turkish clinical laboratories remains at an early stage but is met with strong professional interest. Overcoming structural barriers through standardized education, infrastructure investment, and clear legal frameworks is essential for sustainable AI implementation in clinical laboratories.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Automated Microbial Diagnostics
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.